The damage-inducible UmuD and UmuC proteins are required for most SOS mutagenesis in Escherichia coli. Our recent assay to reconstitute this process in vitro, using a native UmuD 2 C complex, revealed that the highly purified preparation contained DNA polymerase activity. Here we eliminate the possibility that this activity is caused by a contaminating DNA polymerase and show that it is intrinsic to UmuD 2 C. E. coli dinB has recently been shown to have DNA polymerase activity (pol IV). We suggest that UmuD 2 C, the fifth DNA polymerase discovered in E. coli, be designated as E. coli pol V. In the presence of RecA, ␤ sliding clamp, ␥ clamp loading complex, and E. coli single-stranded binding protein (SSB), pol V's polymerase activity is highly ''error prone'' at both damaged and undamaged DNA template sites, catalyzing efficient bypass of abasic lesions that would otherwise severely inhibit replication by pol III holoenzyme complex (HE). Pol V bypasses a site-directed abasic lesion with an efficiency about 100-to 150-fold higher than pol III HE. In accordance with the ''A-rule,'' dAMP is preferentially incorporated opposite the lesion. A pol V mutant, UmuD 2 C104 (D101N), has no measurable lesion bypass activity. A kinetic analysis shows that addition of increasing amounts of pol III to a fixed level of pol V inhibits lesion bypass, demonstrating that both enzymes compete for free 3-OH template-primer ends. We show, however, that despite competition for primer-3-ends, pol V and pol III HE can nevertheless interact synergistically to stimulate synthesis downstream from a template lesion.
Although cellular DNA damage results in the induction of at least 30-40 proteins as part of the global SOS response in Escherichia coli (1) (2) (3) , only two LexA-regulated genes, umuD and umuC, are required to observe DNA damage-induced mutagenesis (4) . The Umu-dependent process of translesion DNA synthesis allows cells to survive in the presence of relatively high levels of replication-inhibiting DNA damage, but at the cost of an increased mutation rate (5, 6) . Damageinducible UmuD 2 does not facilitate translesion DNA synthesis; under certain conditions, it inhibits it (7) . Translesion DNA synthesis is achieved after UmuD 2 undergoes a RecAmediated intermolecular cleavage reaction (8) generating a shorter active UmuDЈ 2 protein (9-11). The combination of UmuDЈ 2 with UmuC forms a mutagenically active UmuDЈ 2 C complex that is stable and resistant to proteolytic degradation (12) (13) (14) .
The current ''working'' model for SOS-induced mutagenesis posits that pol III holoenzyme complex (HE) becomes stalled at a DNA template lesion, at which point UmuDЈ 2 C binds the tip of an activated RecA protein (RecA*)-coated DNA filament, bringing the Umu mutagenic complex in contact with the stalled pol III complex (15) . Genetic data suggested that pol III might incorporate a nucleotide opposite a lesion while Umu could then be involved in shepherding the polymerase past the damaged template site (16, 17) .
Recently, we reconstituted an SOS mutagenesis assay in vitro using UmuDЈ 2 C purified as a native soluble complex (12) to copy a site directed abasic template lesion (18) . Guided by the genetic data, we anticipated that lesion bypass would require the concerted action of at least three protein complexesUmuDЈ 2 C, RecA*, and pol III HE. Indeed, we found that vigorous UmuDЈ 2 C-dependent lesion bypass occurred in the presence of pol III HE, also requiring RecA* (18) .
However, we were surprised to find that the bypass reaction appeared equally efficient when pol III core was omitted from the reaction, prompting us to suggest that UmuDЈ 2 C might be an ''error-prone'' E. coli DNA polymerase (18) . Thus, although we have proposed that ''Umu might contain a distinct polymerizing component'' (18) , the unlikely possibility remained that the incorporation errors observed at normal and aberrant template sites might be caused by the presence of a minute pol III or pol II contaminant whose properties were altered in the presence of UmuDЈ 2 C. In this paper, we provide data that eliminate the possibility that UmuDЈ 2 C is contaminated by either pol III or pol II and confirm that UmuDЈ 2 C is a bona fide ''error-prone'' DNA polymerase (E. coli pol V). E. coli DinB protein has recently been shown to have DNA polymerase activity and has been designated as pol IV (19) .
MATERIALS AND METHODS
Materials. Ultrapure ATP and deoxyribonucleoside triphosphates were purchased from Amersham Pharmacia, and [␥-32 P]ATP (4,000 Ci͞mmol; 1 Ci ϭ 37 GBq) was obtained from ICN. Purification of pol III and its accessory proteins was carried out as described (20) . Pol I antibody was a generous gift from Lawrence Loeb (University of Washington, Seattle). E. coli single-stranded binding protein (SSB) and RecA protein were purchased from Amersham Pharmacia. Other materials have been described previously (18) .
Strains and Plasmids. Although UmuDЈ 2 C has been highly purified, we could not entirely rule out that its associated polymerase activity was caused by low levels of pol II or pol III (18) . To address this issue, we have constructed a strain, RW588, carrying a deletion of the polB locus and a mutation (dnaE1026) rendering pol III temperature sensitive (21, 22) . RW588 (⌬umuDC596::ermGT ⌬polB⍀spc dnaE1026 uvrA6)
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. §1734 solely to indicate this fact. was constructed by P1 transduction of the dnaE1026 allele into DV08 (23) , by selecting for Pro ϩ transductants and screening for dnaE1026-associated temperature sensitivity. The FЈIQ from DH5␣FЈIQ (GIBCO͞BRL) was transferred into RW588 and the strain transformed with the ptacUmuDЈC overproducing plasmid, pOS1 (12) . A second approach was to purify a mutant UmuDЈ 2 C by subcloning the umuC104 allele (6, 24) as an MluI-HindIII fragment from pRW124-104 (25) into a similarly digested pOS1 vector to generate pRW392. Partial Purification of UmuD 2 C Complex from a dnaE1026 ⌬polB Strain. The earlier purification steps were carried out as described (18) . In addition, the cell debris obtained after cell lysis was reextracted with R buffer (20 mM Tris⅐HCl, pH7.5͞ 0.1 mM EDTA͞1 mM DTT͞20% glycerol) with 1 M NaCl and precipitated with polyethyleneimine (1.1% wt͞vol). The lysate and supernatant containing UmuDЈ 2 C were combined and precipitated twice with ammonium sulfate (18) . Proteins from the second ammonium sulfate precipitation were centrifuged, resuspended, and dialyzed in R buffer containing 1 M NaCl. The dialyzed proteins were loaded onto a Superdex 200 size exclusion column (16͞60, Amersham Pharmacia) and run in R buffer with 1 M NaCl, but containing no glycerol. Fractions (1.1 ml) were collected, and glycerol was added to individual fractions to reach a final concentration of 20%. Fractions containing UmuDЈ 2 C proteins were visualized by staining with Coomassie blue R-250, resolved on a 12% SDS͞PAGE gel. Fractions containing pol III temperature sensitive (ts) were detected by Western blotting by using antiserum directed against ␣ subunit. The mutant UmuDЈ 2 C104 (D101N) protein, isolated from a wild-type background, was purified in a similar manner except that gel filtration was carried out by using Superdex 75 (26͞60, Amersham Pharmacia), followed by phosphocellulose column chromatography (12) .
Replicative Bypass Assay. Translesion bypass reactions were carried out by using a 32 P-labeled primer annealed to a linear 7.2-kb M13 DNA template with an abasic lesion, X, located 50 bases from the 5Ј-end, as described in ref. 18 , with slight modifications. BSA (40 g͞ml) was added to the reactions, and polyethylene glycol was added to a final concentration of 5% (vol͞vol) in a subset of reactions as indicated in the figure legends. Preincubation of UmuDЈ 2 C with other proteins was for 3 min. All reactions were performed in the presence of pol I antibody, which completely neutralized pol I activity. The dNTP concentrations were held constant at 100 M each, unless specified otherwise.
Kinetic Analysis of Nucleotide Incorporation Efficiency Opposite an Abasic Lesion. A gel kinetic analysis was used to determine the rate of abasic translesion synthesis as a function of dNTP concentration (26) . Elongated 32 P-labeled primer extension products were separated by using 16% polyacrylamide denaturing gels. Integrated polyacrylamide gel band intensities were measured with a PhosphorImager by using IMAGEQUANT software (Molecular Dynamics). The efficiency of lesion bypass is determined by measuring I X ⌺ ͞I XϪ1 , where I X ⌺ designates the integrated gel band intensities of primers extended opposite the abasic site, X, and beyond, i.e., translesion synthesis, and I XϪ1 is the integrated gel band intensity of primers extended by addition of a single running-start nucleotide (C) opposite the template site before X (26). Saturation plots of velocity as a function of dNTP concentration were carried out by using SIGMA PLOT software (Jandel, San Rafael, CA). Apparent V max and K m values were obtained from nonlinear least squares fits to a rectangular hyperbola, from a linear least squares fit to the ''linear'' region or from double reciprocal Lineweaver-Burk plots.
RESULTS
The experiments in this paper are focused primarily on determining whether UmuDЈ 2 C has an intrinsic DNA polymerase activity separate from pol II and pol III, even though it requires the same auxiliary proteins (␤ sliding clamp and ␥ clamp loading complex) for optimal activity (18) . Our earlier study, showing that UmuDЈ 2 C copies past abasic template lesions in the absence of exogenous DNA polymerase (18) , contained the caveat that UmuDЈ 2 C might contain trace contaminants of either pol III core, ␣ subunit, or perhaps pol II. To eliminate this possibility, we have now purified UmuDЈ 2 C from an E. coli mutant strain containing a deletion of pol II (⌬polB) (27) and a temperature-sensitive allele of DNA polymerase III (dnaE1026) (28) .
UmuD 2 C Is a DNA Polymerase, E. coli pol V. Cell lysates were enriched for soluble UmuDЈ 2 C complex by precipitation with polyethyleneimine and then with ammonium sulfate (12, 18) . The UmuDЈ 2 C-enriched fraction was run on a highresolution Superdex 200 column, and individual fractions were assayed for the presence of pol III ␣ subunit by Western blots (Fig. 1 Upper) and for UmuC by using a Coomassie-stained gel (Fig. Lower) . Western blots with polyclonal antibodies directed against UmuC and UmuDЈ showed that the fractions containing the UmuDЈ 2 C complex correspond precisely to the locations determined with the Coomassie-stained gel (data not shown).
Three Superdex fractions were chosen to measure polymerase and abasic lesion bypass activities: fraction (fx) 50 contains predominantly pol IIIts core with a small amount of UmuDЈ 2 C; fx 56 contains overlapping pol IIIts ϩ UmuDЈ 2 C; fx 64 contains UmuDЈ 2 C having no detectable pol IIIts present (Fig. 2) . The lesion bypass assay (7, 18) is performed by using a 32 P-labeled 30-mer primer annealed to a linear M13 DNA template containing a single abasic lesion located two positions downstream from the primer-3Ј-end (Fig. 2) . Primer extension is carried out with each of the three fractions in the presence of RecA, ␤, ␥ complex, SSB, 4 dNTP substrates, and ATP. Extended primers are separated according to length by PAGE and visualized by PhosphorImaging. A single running-start nucleotide (dCMP) is incorporated opposite template G to reach the abasic lesion X. A primer band extended directly opposite X corresponds to nucleotide incorporation directly opposite the lesion. Longer primer extension bands reflect synthesis proceeding past the lesion site, i.e., lesion bypass.
At the permissive temperature (37°C), fx 50 (containing pol IIIts) incorporates a running-start C opposite G along with a small amount of incorporation opposite X and 1 nt beyond, but all synthesis is essentially absent at the nonpermissive temperature of 47°C (Fig. 2 ). The extremely weak lesion bypass band observed at 37°C can be attributed to the presence of a small amount of UmuDЈ 2 C ( Fig. 1 ; see e.g. ref. 18 ). In contrast, fx 64, which contains no detectable pol IIIts, carries out runningstart incorporation and lesion bypass at both permissive and nonpermissive temperatures (Fig. 2) . We conclude, therefore, that UmuDЈ 2 C has its own polymerase activity that can incorporate a running-start C opposite G in a template- directed reaction and can also catalyze nucleotide incorporation and continued extension at an abasic template lesion. Polymerization carried out by fx 56 (UmuDЈ 2 C ϩ pol IIIts) revealed an interesting result. The robust incorporation and lesion bypass observed at 37°C is consistent with our previous observation that UmuDЈ 2 C catalyzes incorporation directly opposite X and then extends several bases beyond the lesion, at which point UmuDЈ 2 C dissociates and is replaced by pol III HE (18) . However, unexpectedly, this synergistic effect on downstream synthesis also occurs at the nonpermissive temperature. As seen in Fig. 2 , the amount of total DNA synthesis is much greater for fx 56 (UmuDЈ 2 C ϩ pol IIIts) compared with essentially no DNA synthesis for fx 50 (pol IIIts) and moderate synthesis for fx 64 (UmuDЈ 2 C). It appears that the temperature-sensitive mutant pol III is stabilized in the presence of high concentrations of UmuDЈ 2 C, suggesting that the two polymerases might interact in the vicinity of the lesion. Perhaps once lesion bypass has occurred, normal DNA replication can resume by replacing a distributive Umu polymerase (18) with a processive pol III HE.
We investigated requirements for the other protein cofactors by permuting RecA, ␤, ␥ complex, and SSB in the lesion bypass reactions (Fig. 3) . We observed that UmuDЈ 2 C alone clearly catalyzes incorporation of the running-start C but cannot measurably catalyze further extension opposite the lesion (lane 1). Inclusion of either ␤, ␥ complex (lane 2), SSB (lane 3), or RecA (lane 5) stimulates incorporation of C, but there is essentially no incorporation opposite X. Weak UmuDЈ 2 C-catalyzed incorporation opposite X occurs in the presence of ␤, ␥ complex ϩ either SSB (lane 4) or RecA (lane 6), but lesion bypass is not observed. However, a strong lesion bypass signal was observed once RecA was included along with these other three components (lane 8). Indeed, RecA appears to be the most important stimulatory factor required for translesion synthesis by UmuDЈ 2 C.
Primer extension was reduced significantly when dCTP was omitted from the reaction (lane 9). The small amount of synthesis occurring in the absence of dCTP can be attributed to UmuDЈ 2 C-catalyzed misincorporation found to occur at undamaged template sites (18) . Note the presence of a termination band appearing before the second template G (lane 9) that disappears when all four dNTPs are present (lane 8). These data demonstrate that UmuDЈ 2 C is behaving as a DNA polymerase, not a terminal deoxynucleotidyl transferase. A mutant UmuDЈ 2 C complex containing UmuC104 (D101N) cannot copy past the abasic lesion (lane 11), thereby confirming that the error-prone polymerase activity is intrinsic to UmuDЈ 2 C and cannot be explained by contamination with some other polymerase, e.g., the recently discovered pol IV (DinB) (19).
FIG. 2. UmuDЈ2C (E.
coli polV) has DNA polymerase activity. UmuDЈ2C was purified from a ⌬polB dnaE1026ts strain, RW588. Sephadex 200 fractions fx (50) containing predominantly pol IIIts; fx (56) containing pol IIIts ϩ UmuDЈ2C and fx (64) containing UmuDЈ2C having no detectable pol IIIts were assayed for polymerase activity by extension of a 32 P-labeled 30-mer primer annealed to a linear M13 DNA template, at permissive (37°C) and nonpermissive (47°C) temperatures. A single running-start base, C, is incorporated opposite G to reach the abasic lesion, X. The left-hand lane contains the primer (P) in the absence of proteins. Each reaction mixture contains 1.5 l of the indicated fraction from a Superdex 200 gel filtration column (Fig. 1) . All reactions were carried out in the presence of pol I antibody, RecA, SSB, ␤, ␥ complex, 4 dNTPs, and ATP. (Fig. 4) . A running-start reaction, in which a single nucleotide (C) is incorporated before reaching the abasic lesion, was used to measure incorporation directly opposite and downstream from the abasic lesion as a function of dATP substrate concentration. Two pol III HE forms were used, one containing the proofreading-proficient pol III core (␣, , and subunits) (Fig. 4A ) and the second form containing ␣, in the absence of and (Fig. 4B) . RecA, ␤ sliding clamp, ␥ clamp loading complex, and SSB were present in all reactions.
In the absence of pol III, UmuDЈ 2 C incorporates A opposite X, and further extension to the next template site occurs by incorporation of an A⅐A mispair (Fig. 4) . In contrast, ␣ HE incorporates a much lower amount of A opposite X with no observable bypass, while pol III HE shows hardly any incorporation of A even at high dATP concentration (300 M).
A key result is that the rate of UmuDЈ 2 C-catalyzed lesion bypass is reduced significantly as the concentration of either of the two pol III HE forms is increased. It is important to emphasize that we are measuring lesion bypass synthesis as the amount of incorporation opposite the lesion and extension past the lesion, normalized to the amount of primer extended by incorporation of running-start C to reach the lesion site. Although incorporation of running-start C just before the lesion is strongly stimulated as the concentration of pol III is increased relative to UmuDЈ 2 C, the efficiency of translesion synthesis is reduced substantially. In other words, the presence of pol III HE at the primer-3Ј-end prevents UmuDЈ 2 C from binding at the lesion site.
A double reciprocal plot of the data is used to illustrate this important point (Fig. 5) . We observe that the apparent K m values for incorporation of A opposite X and opposite the downstream A are relatively insensitive to the concentration of either pol III or ␣ holoenzymes. The apparent K m values are roughly the same compared with UmuDЈ 2 C alone (Ϸ 12 to 23 M) and are approximately 20-and 40-fold lower than for the pol III HE and ␣ HE, respectively (Fig. 5) . This apparent noncompetitive inhibition of UmuDЈ 2 C by pol III, with respect to dNTP incorporation at X, implies that UmuDЈ 2 C and pol III are competing for the same primer-3Ј-ends. Thus, whenever UmuDЈ 2 C succeeds in binding to a primer-end and catalyzes bypass synthesis in the presence of pol III, it does so with a characteristically low K m value. Conversely, large reductions in V max occur because there are fewer bound UmuDЈ 2 C-primertemplate DNA complexes because of competition by pol III.
The kinetic data reveal two other important points: (i) UmuDЈ 2 C catalyzes bypass synthesis with at least 100-fold higher efficiency than pol III, either with or without proofreading; (ii) A is favored for incorporation opposite the abasic lesion by roughly 3-fold over G (data not shown), in accordance with the ''A-rule'' (29) . Incorporation of either C or T opposite X is barely detectable (data not shown).
DISCUSSION
When pol III HE was used in an earlier study to copy a site-directed abasic template lesion in vitro, the two aberrant polymerase reactions, insertion of a nucleotide opposite the lesion and bypass of the lesion by incorporating a ''nextcorrect'' nucleotide, were barely detectable (18) . But both reactions were stimulated strongly when UmuDЈ 2 C, RecA, and SSB were included in the reaction. Remarkably, however, omitting pol III core had essentially no effect on lesion bypass. These data led us to suggest that UmuDЈ 2 C is an error-prone DNA polymerase that incorporates a nucleotide opposite a damaged template site and then synthesizes past the lesion (18) . However, we could not definitively rule out that lesion bypass might be caused alternatively by contamination with minute amounts of pol III or pol II exhibiting drastically reduced fidelity in the presence of UmuDЈ 2 C. UmuD 2 C Is an Error-Prone DNA Polymerase, E. coli pol V. Several lines of evidence are presented in this paper demonstrating that UmuDЈ 2 C has a polymerase activity distinct from pol III or pol II. We purified an intact native UmuDЈ 2 C complex from cells lacking pol II and containing a temperature-sensitive mutant pol III. UmuDЈ 2 C and pol IIIts were separated by Superdex 200 gel filtration (Fig. 1) , and three column fractions were used to investigate bypass of a sitedirected abasic lesion (Fig. 2) . One fraction (fx 50) contained the pol IIIts peak along with a small amount of UmuDЈ 2 C, while another (fx 64) contained UmuDЈ 2 C peak with no detectable pol IIIts (Fig. 1) . We also investigated the properties of a third fraction (fx 56) enriched for UmuDЈ 2 C but having a small, yet significant, amount of pol IIIts.
In the assay, 32 P-labeled primer is extended by adding a single running-start nucleotide (dCTP) before reaching an abasic template site, X. In contrast to pol IIIts (fx 50), which incorporates C opposite G at 37°C, but whose activity is reduced substantially at 47°C, UmuDЈ 2 C (fx 64) incorporates C and catalyzes lesion bypass at both permissive and nonpermissive temperatures (Fig. 2) . Thus, UmuDЈ 2 CЈs polymerase activity cannot be explained by the presence of pol III. Contamination with pol II is ruled out because a ⌬polB strain was used to overexpress UmuDЈ 2 C, and pol I is ruled out because the assays were performed in the presence of large excess of neutralizing antibody directed against pol I. We also verified that UmuDЈ 2 C104 fails to catalyze lesion bypass (Fig.  3, lane 11) , demonstrating that the data cannot be attributed to any other polymerase such as pol IV (DinB) (19) .
Accessory Proteins Required for UmuD 2 C-catalyzed Lesion Bypass. UmuDЈ 2 C-catalyzed lesion bypass requires the presence of activated RecA (Fig. 3, ref. 18 ), in agreement with genetic data (11, 30, 31) . However, we find that Umu-catalyzed bypass also requires the presence of ␤, ␥ complex and SSB, in addition to RecA (Fig. 3, lanes 9 and 10; ref. 18) . Indeed, incorporation of a running-start nucleotide at an undamaged template site is stimulated in the presence of each of these accessory proteins (Fig. 3) . Because UmuDЈ 2 C polymerase activity appears to be highly distributive, it will be interesting to determine whether the ␤ processivity clamp might be responsible for stabilizing the Umu-DNA complex in the vicinity of a lesion.
Pol III and UmuD 2 C Compete for Primer-3-OH Ends. Kinetic data show that UmuDЈ 2 C-catalyzed lesion bypass activity is reduced as the concentration of pol III is increased, a result that cannot be attributed to pol III proofreading (Fig.  4) . The fact that catalysis by pol III at a lesion site is negligible compared with UmuDЈ 2 C enables a straightforward interpretation of the kinetic data. The observation that V max is reduced by addition of pol III while the apparent K m for lesion bypass is essentially the same as for UmuDЈ 2 C alone indicates that both enzymes are able to bind primer-3Ј-ends, providing strong independent evidence that UmuDЈ 2 C is a low-fidelity DNA polymerase.
How can these data be reconciled with genetics experiments that have shown a clear requirement for pol III in SOS mutagenesis (16, 32) ? Our experiments show that UmuDЈ 2 C is not processive and is unlikely to be able to duplicate the 4.6-Mb E. coli chromosome, a task normally performed by pol III HE. Pol III HE must, therefore, take over from UmuDЈ 2 C once bypass has occurred. Indeed, our data showing that UmuDЈ 2 C appears to stabilize pol IIIts (Fig. 2) imply that pol III and UmuDЈ 2 C may physically interact near the site of a lesion. If this interpretation is valid, then one can visualize how UmuDЈ 2 C might displace pol III core blocked at template lesion, interact with ␤, RecA*, and SSB to copy past the lesion, and subsequently be released from the DNA to allow reentry of pol III several bases downstream.
UmuC belongs to a large superfamily of proteins that can be broadly subclassified into UmuC-like, DinB-like, Rev1-like, and Rad30-like proteins (33, 34) . Our finding that UmuDЈ 2 C is a DNA polymerase means that the prototype for each subfamily has been shown to possess the ability to catalyze phosphodiester bond formation. UmuC, DinB, and Rad30 appear to be bona fide polymerases (this paper and refs. 19, Proc. Natl. Acad. Sci. USA 96 (1999) 35), whereas Rev1 is a template-directed dCTP transferase (36) . One unusual characteristic of UmuDЈ 2 C, however, is its complex dependence on a diverse group of other proteins, RecA*, ␤, ␥ complex, and SSB to perform its main function in copying past replication blocking lesions. The availability of a reconstituted lesion bypass assay in vitro (18, 37) should permit the elucidation of each of these interactions and their specific roles in translesion DNA synthesis.
